Skip to content

Effects of magnetotherapy and lumbar traction on the patients of sciatica

Effects of magnetotherapy and lumbar traction on the patients of sciatica

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20210822052250N1
Enrollment
60
Registered
2022-06-24
Start date
2022-08-01
Completion date
Unknown
Last updated
2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sciatica. Sciatica

Interventions

Intervention 1: Intervention group 1: In this group, patients with sciatica are exposed to regular soft tissue release, isometric exercises, stretching and Lumbar traction. these individuals are not e

Sponsors

Green international University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
25 Years to 60 Years

Inclusion criteria

Inclusion criteria: Having mechanical neck pain more than three months and less than two years age between 25 and 60 years having normal laboratory test results absence of fracture, dislocation, tumor or infection on radiological investigation pain severity of at least 4/10 according to the visual analog scale (VAS) willingness to sign the informed consent form. Presence of disc bulge, protrusion or herniation at L4-L5, and L5-S1 level

Exclusion criteria

Exclusion criteria: pregnancy and breastfeeding having a cardiac pacemaker implanted metal implant or electronic device in any part of body a prior trauma (whiplash), surgical or algological intervention in lumbar area history or suspicion of any malignancy presence of inflammatory joint pain or diagnosis of a rheumatic disease presence of an open superficial wound presence of more severe pain in any part of body other than low back pain an advanced stage mood disorder, a neurological disorder (multiple sclerosis, syringomyelia, or Parkinson’s disease) radiographical Grade =2 spondylolisthesis, spinal instability or advanced spondylarthrosis physical therapy for back pain within the last six months a history of drug use other than paracetamol (NSAIDs, centrally acting and narcotic analgesics) or discontinuation of such drugs less than three months before the enrolment.

Design outcomes

Primary

MeasureTime frame
Daily overall pain level. Timepoint: 3 days. Method of measurement: scale of 0 to 10.;Pain in the low back. Timepoint: 3 days. Method of measurement: 0-10 pain scale.;Pain in the lower extremities. Timepoint: 3 days. Method of measurement: 0-10 pain scale.

Secondary

MeasureTime frame
Quality of life. Timepoint: 3 days. Method of measurement: questionnaire: SF 36.

Countries

Pakistan

Contacts

Public ContactDr. Mohtishim Ahmed

Green international university, lahore

mohtishimahmed77@gmail.com+92 313 4414456

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026